| Literature DB >> 34833987 |
Yunbing Tan1, David Julian McClements1,2.
Abstract
The supplementation of plant-based foods and beverages with bioactive agents may be an important strategy for increasing human healthiness. Numerous kinds of colloidal delivery systems have been developed to encapsulate bioactives with the goal of improving their water dispersibility, chemical stability, and bioavailability. In this review, we focus on colloidal delivery systems assembled entirely from plant-based ingredients, such as lipids, proteins, polysaccharides, phospholipids, and surfactants isolated from botanical sources. In particular, the utilization of these ingredients to create plant-based nanoemulsions, nanoliposomes, nanoparticles, and microgels is covered. The utilization of these delivery systems to encapsulate, protect, and release various kinds of bioactives is highlighted, including oil-soluble vitamins (like vitamin D), ω-3 oils, carotenoids (vitamin A precursors), curcuminoids, and polyphenols. The functionality of these delivery systems can be tailored to specific applications by careful selection of ingredients and processing operations, as this enables the composition, size, shape, internal structure, surface chemistry, and electrical characteristics of the colloidal particles to be controlled. The plant-based delivery systems discussed in this article may be useful for introducing active ingredients into the next generation of plant-based foods, meat, seafood, milk, and egg analogs. Nevertheless, there is still a need to systematically compare the functional performance of different delivery systems for specific applications to establish the most appropriate one. In addition, there is a need to test their efficacy at delivering bioavailable forms of bioactives using in vivo studies.Entities:
Keywords: bioactives; colloidal systems; emulsions; functionality; plant-based delivery
Mesh:
Substances:
Year: 2021 PMID: 34833987 PMCID: PMC8625429 DOI: 10.3390/molecules26226895
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Emulsion stabilization mechanisms: molecular versus particle emulsifiers.
Figure 2Schematic diagram of different types of delivery systems that can be assembled from plant-based ingredients.
Figure 3(a) Illustration of the environmental conditions in the gastrointestinal tract; (b) Rapid- and slow-release patterns of encapsulated bioactives.
Figure 4Some critical factors that determine the functional performance of nanoemulsion delivery systems.
Encapsulation properties, stability, and gastrointestinal fate of different types of delivery systems for hydrophobic bioactives.
| Delivery System Type | Size | Charge | Composition | Loading Properties | Stability | Digestion Properties | References |
|---|---|---|---|---|---|---|---|
| Nanoparticle, nanoliposome, nanoemulsion | Nanoparticle and nanoliposome: 99 nm; nanoemulsion: 168 nm | Nanoparticle: 20 mV; nanoliposome: −5.2 mV; nanoemulsion: −6.5 mV | Curcumin; zein nanoparticle; phospholipid nanoliposome; Tween 20 stabilized corn oil nanoemulsion | Loading capacity: nanoparticle: 12%; nanoliposome: 3%; nanoemulsion 0.4% | Chemical stability of curcumin in GIT: nanoemulsion ≈ nanoparticle > nanoliposome | Curcumin bioaccessibility: nanoemulsion (92%) > nanoliposome (74%) > nanoparticle (52%) | [ |
| Nanoparticle | 86–200 nm | −27 to −11 mV as increasing calcium level | Vitamin D; zein nanoparticles with different levels of carboxymethyl chitosan and calcium | Loading capacity decreased from 3.9 to 1.7%; encapsulation efficiency increased from 52% to 88% as increasing chitosan or calcium level. | Photochemical stability increased from ~70% to 80% with the chitosan coating, compared to 30% of free vitamin D. | Vitamin D release in the GIT decreased with the chitosan coating (~55%) compared to ~100% for zein nanoparticles. | [ |
| Nanoparticle | 267–728 nm as increasing calcium level | −23 to −14 mV as increasing calcium level | Resveratrol; zein-propylene glycol alginate-tea saponin complex at different calcium level | Encapsulation efficiency increased with tea saponin (58% to 77%), irrespective of calcium level. Loading capacity was the same for all treatments. | Tea saponin increased photo and thermal stability of resveratrol; calcium increased the environmental stability (thermal, pH, ionic) of the particle. | Calcium reduced the release of resveratrol in the stomach but promoted the release in the small intestinal phase. | [ |
| Solid lipid nanoparticle (SLN), nanoemulsion | Corn oil: 0.5 μm; cocoa butter: 0.9 μm | Corn oil: −29 mV; cocoa butter: −42 mV | β-Carotene; cocoa butter, cocoa oil, corn oil, Tween 80 | - | β-Carotene stability decreased in cocoa oil with a compact crystalized lipid core and in small oil droplet size. | Triglycerides (TAG) disappearance: 90% for both; bioaccessibility: 64% for corn oil, 82% for cocona butter. | [ |
| Nanostructured lipid carrier (NLC) | 94 nm | −24 mV | Astaxanthin; oil phase: glyceryl behenate, oleic acid, lecithin, α-tocopherol; aqueous phase: Tween 80 and EDTA | - | Carbonation and thermal pasteurization increased particle size and astaxanthin loss. | - | [ |
| SLN, NLC | <200 nm | −40 to −20 mV | Curcumin; oil phase: glyceryl behenate (SLN) or mixed with oleic acid oil (NLC); aqueous phase: casein, Tween 80, pectin | Tween 80, oil blending, and pectin coating improved loading capacity and encapsulation efficiency (~35% to 66%). | The size of SLN was more stable than NLC during storage. | SLN showed less curcumin release than NLC. | [ |
| Microgel | Alginate: 626 μm; carrageenan: 849 μm; mixture: 763 μm | Alginate: −24 mV; carrageenan: −16 mV; mixture: −21 mV | Corn oil droplets stabilized by Tween 80; gelling structure: alginate, carrageenan, and mixture | - | Alginate beads were intact, while carrageenan beads were deformed and dissociated in the GIT. | The free fatty acid (FFA) release rate decreased as carrageenan (~80%), mixture, alginate (~50%). | [ |
| Emulsion, microgel bead | Emulsion: 0.27 μm; alginate bead: ~400 μm; chitosan bead: ~250 μm | Emulsion: −20 mV; alginate beads: −17 mV; chitosan beads: −23 mV at pH 7 | Curcumin; emulsion: corn oil droplets stabilized by Tween 80; microgel beads: alginate vs. chitosan | High encapsulation of the lipid droplets in both alginate and chitosan beads. | At pH 7, curcumin degradation under 55 °C increased as: chitosan < emulsion < solution < alginate; at pH 3, the order was: emulsion < solution < chitosan < alginate. | - | [ |
| Nanoemulsion vs. microgel | Nanoemulsion: 0.2 μm; microgel: ~500 μm | Nanoemulsion: −74 mV; microgel: −46 mV | Flaxseed oil nanoemulsion stabilized by quillaja saponin; alginate microgel bead; casein as an antioxidant | - | Particle size was the same under 55 °C. Microgel inhibited lipid oxidation (hydroperoxides and TBARS). | FFA release: ~100% for emulsion, ~50% for microgel | [ |
| Microgel | Chitosan microgel was much smaller than gelatin microgel | - | (-)-Epigallocatechin gallate (EGCG); microgel beads: gelatin vs chitosan | Encapsulation efficiency: 95% for gelatin; 82% for chitosan | The initial release of the EGCG was faster in the chitosan microgel, but the final release was the same. | Release of EGCG reduced as: Gelatin > chitosan, which was significantly less than free EGCG. | [ |
| Emulsion | 0.15, 1.6, 11 μm | −68 to −57 mV | Vitamin A, D, E; soy oil emulsion stabilized by quillaja saponin | - | Oil droplet size remained unchanged during GIT. Vitamin stability in GIT was the same for different oil droplet sizes. | FFA release decreased from 125% to 99% as increasing oil droplet size. Bioaccessibility: vitamin A: 87%, 68%, 39%; vitamin D: 76%, 76%, 44%; vitamin E: 77%, 40%, 21% as increasing oil droplet size. | [ |
| Emulsion | Pea protein: 36 μm; complex with flaxseed gum: 20 to 54 μm | Pea protein: 33 mV; complex with flaxseed gum: −3 mV | Algae oil emulsion stabilized by pea protein with or without flaxseed gum | - | The emulsion was stable in pure protein or high flaxseed gum level but unstable at low flaxseed gum level (0.01%). Flaxseed gum reduces lipid oxidation and the release of undesirable volatiles. | - | [ |
| Emulsion | 0.3–0.4 μm | −25 to −20 mV | Fish oil droplets stabilized by lentil, pea, and faba bean proteins | - | All emulsions were unstable in stomach or under different pH, ionic strength, temperature. Lentil protein emulsion was most stable. All plant proteins inhibited lipid oxidation. | FFA reached 100% for all samples. | [ |
| Emulsion | Quillaja saponin: 0.13 μm; gum arabic: 0.33 μm | Quillaja saponin: −63 mV; gum arabic: −32 mV | β-Carotene; flaxseed oil droplets stabilized by either quillaja saponin or gum arabic, tannic acid as an antioxidant | - | Emulsions were relatively stable at 55 °C and in GIT. | Quillaja saponin slightly reduced lipid digestion to 90%. The β-carotene bioaccessibility was the same (45%) for all emulsions. | [ |
| Emulsion | Tween 20, quillaja saponin and casein: 0.17 μm; lysolecithin: 0.33 μm; gum Arabic: 0.48 μm | Casein, lysolecithin and gum Arabic: −42 to −33 mV; quillaja saponin: −72 mV; Tween 20: −18 mV | β-Carotene, corn oil droplets stabilized by Tween 20, quillaja saponin, casein, gum arabic, or lysolecithin | - | Casein and lysolecithin stabilized emulsions were unstable in GIT. | FFA release: Tween 20 and quillaja saponin (>100%) > gum arabic (99%) > soy lysolecithin and casein (93%); β-carotene bioaccessibility: Tween 20 (62%) > quillaja saponin (56%) > casein (55%) > gum arabic (51%) > lysolecithin (25%). | [ |
| Excipient emulsion | 0.2, 0.5, 10 μm | −72 to −42 mV as increasing oil droplet size | Carotenoids from carrots; whey protein stabilized corn oil emulsion | - | The emulsion was unstable in the stomach phase. | FFA release: over 100% for 0.2 and 0.5 μm, >90% for 10 μm and bulk oil; Bioaccessibility: α-carotene and β-carotene decreased as increasing oil droplet size (32% to 7%). | [ |
| Excipient emulsion | 0.7–0.9 μm | - | Carotenoids from carrot or tomato purees, sucrose ester, stabilized emulsion, olive (OO), soybean (SO), or linseed (LO) oils | - | All emulsions were unstable in the stomach phase. | TAG disappearance: 43–44% for OO, 42–45% for SO, 34–36% for LO. Bioaccessibility: β-carotene from carrots: 13% for OO, 8–10% for SO and LO; cis-lycopene from tomato 27% for OO, 15% for SO and LO. | [ |
| Excipient emulsion | <0.2 μm | LCT: −23 mV; MCT: −14 mV | Carotenoids and phenolics from mangoes; Tween 20 stabilized emulsion: corn oil (LCT) vs. MCT | - | All emulsions were stable in GIT. | FFA release: MCT (>100%) > LCT (80%). Phenolics bioaccessibility: 80%, 100%, 80%; carotenoids bioaccessibility: 35%, 60%, 80%, for buffer solution, MCT, LCT emulsions respectively. | [ |
| Emulsion | <0.2 μm | −45 mV | Curcumin loaded by pH driven method, heat-driven method, or conventional oil loading method; corn oil emulsion stabilized by quillaja saponin | Encapsulation efficiency: pH driven (93%) > heat-driven (76%) > conventional oil loading (56%) | Emulsions were stable in GIT. | FFA release (~80%), curcumin stability (76–92%) and bioaccessibility (74–79%) were similar. | [ |
| Nanoemulsion | ~0.2 μm | −46 to −40 mV | Vitamin E acetate, quillaja saponin stabilized emulsions: corn oil (LCT) or MCT | - | - | FFA release: MCT (> 100%) > LCT (~80%); vitamin E bioaccessibility: LCT (39%) >MCT (17%); vitamin E conversion: LCT (29%) > MCT (17%) | [ |
| Emulsion and nanoemulsion | 0.2, 20 μm | −60 to −50 mV | Vitamin D; corn oil emulsion stabilized by quillaja saponin | - | - | FFA release: 100% to 69%; vitamin D bioaccessibility: 1.8 μg/mL, 0.5 μg/mL; bioavailability: 22 ng/mL, 18 ng/mL as increasing oil droplet size | [ |
| Emulsion | <0.2 μm | −70 to −60 mV | Curcumin, resveratrol, and quercetin; quillaja saponin stabilized emulsion: coconut, sunflower, and flaxseed oil | Encapsulation efficiency: 70–90%, higher in long-chain TAGs | Long-chain TAG promoted higher gastrointestinal stability of polyphenol. | Long chain TAG and resveratrol retarded lipid digestion. Resveratrol: 86%, 80%, 77%; curcumin: 52%, 53%, 59%; quercetin: 48%, 75%, 69%, for coconut oil, sunflower oil and flaxseed oil respectively. | [ |